Hotgen Biotech has been deeply engaged in the biomedical field for over 20 years and is the first IVD company listed on the STAR Market of the Shanghai Stock Exchange (688068.SH). Its Up‑converting Phosphor Technology Platform is the only platform in China that has received the National Technology Invention Award.

AKK2645 is a research-grade postbiotic from Besbio's 20,000+ strain library, validated by peer-reviewed studies in safety, colitis, and metabolism, with full safety data—and we are advancing its applications across Besbio products.

Besbio has been rigorously tested by accredited authorities, ensuring safety and efficacy with recognized certifications. It holds GRAS certification, SGS testing reports, and other authoritative verifications. Product efficacy is further supported by human clinical studies from Hunt Biotech and zebrafish model efficacy reports.

Besbio's factory in New Jersey, USA, holds FDA‑recognized production qualifications and strictly adheres to cGMP (Current Good Good Manufacturing Practice) standards in its operations.

AKK2645, a proprietary Besbio strain from its exclusive collection with pending patents and strain deposits, is pasteurized to deliver greater safety, efficacy, and stability than live bacteria.

Raw materials transport: We has long-term cooperation agreement with the logistics companies in Xinjiang,